Analyzing PACS Group (PACS) and Its Competitors

PACS Group (NYSE:PACS) is one of 93 public companies in the “Medical Services” industry, but how does it compare to its rivals? We will compare PACS Group to similar companies based on the strength of its institutional ownership, earnings, analyst recommendations, dividends, risk, profitability and valuation.

Analyst Ratings

This is a summary of current recommendations and price targets for PACS Group and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	1	1	2	0	2.25
PACS Group Competitors	632	2495	5129	184	2.58

PACS Group presently has a consensus target price of $24.67, indicating a potential upside of 70.41%. As a group, “Medical Services” companies have a potential upside of 367.52%. Given PACS Group’s rivals stronger consensus rating and higher probable upside, analysts plainly believe PACS Group has less favorable growth aspects than its rivals.

Profitability

This table compares PACS Group and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PACS Group	N/A	N/A	N/A
PACS Group Competitors	-904.74%	-63.69%	-14.28%

Earnings & Valuation

This table compares PACS Group and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PACS Group	$3.11 billion	$112.87 million	46.69
PACS Group Competitors	$9.89 billion	$239.88 million	11.83

PACS Group’s rivals have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

58.1% of shares of all “Medical Services” companies are owned by institutional investors. 13.3% of shares of all “Medical Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

PACS Group has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, PACS Group’s rivals have a beta of 1.53, meaning that their average stock price is 53% more volatile than the S&P 500.

Summary

PACS Group rivals beat PACS Group on 9 of the 13 factors compared.

About PACS Group

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.